Sep 05, 2024

Pharmacist and health policy specialist comes full circle as patient partner

Jul 15, 2024

Caregiver brings father’s voice to cancer research

May 27, 2024

New 3CTN initiative aims to address barriers faced by underrepresented populations and expand clinical trial involvement

Apr 03, 2024

Ontario cancer community comes together at OICR Translational Research Conference

Mar 22, 2024

Ask a cancer researcher: Is there a blood test for cancer?

Feb 27, 2024

New PFAC Chair takes lead of growing, evolving community of OICR patient partners

Sep 19, 2023

Ask a Cancer Researcher: How does blood change as we age?

Aug 29, 2023

Ask a Cancer Researcher: How can we predict if breast cancer will come back?

Jul 19, 2023

Ask a Cancer Researcher: What happens to samples donated to tumour banks?

Jul 12, 2023

Paying it forward with a patient perspective

Jun 21, 2023

Ask a Cancer Researcher: What is immunotherapy?

Jun 07, 2023

Patient partner driven to make cancer care more inclusive

May 11, 2023

Ask a Cancer Researcher: What happens after a new discovery?

Apr 26, 2023

Ask a Cancer Researcher: Why do we sequence tumour DNA?

Apr 03, 2023

‘Upswing’ in patient partnership presents opportunities for impact, says new PFAC chair

Nov 17, 2022

How patients can improve the way new cancer therapies are assessed

Oct 05, 2022

Patient perspectives fuelling translational OICR studies

Aug 24, 2022

Prostate cancer trial aims to deliver shorter, more effective radiotherapy thanks to advanced imaging

Jun 16, 2022

OICR announces funding for three new window-of-opportunity clinical trials

May 18, 2022

OICR launches new Patient Partnership Plan

May 10, 2022

New research asks if clinical trials are losing sight of what matters most to cancer patients

Apr 06, 2022

New Chair of patient advisory council taking OICR patient partnership into next phase

Mar 04, 2022

Made-in-Canada CAR-T cells save lives in promising clinical trial

Dec 15, 2021

Mapping the Canadian clinical trials landscape in precision oncology to identify trial opportunities for patients, clinicians and researchers

Dec 02, 2021

Ontario Institute for Cancer Research announces funding for sixteen studies that support early detection of cancer, the development of new diagnostics to guide therapy and improved treatment options for patients

Dec 01, 2021

New funding from the Ontario Institute for Cancer Research supports projects developing methods for cancer detection and tools to facilitate better treatment decisions for high-risk cancer patients

Oct 08, 2021

Study puts spotlight on FDA’s accelerated approval of cancer drugs

Mar 30, 2021

Patient reflections from the 2021 OICR Translational Research Conference